Labcorp, one of the country’s largest providers of diagnostic medical testing services, announced today that it will offer ...
Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the only blood test cleared by the U.S. Food and Drug ...
Labcorp announced it will begin offering the Elecsys pTau181 blood test nationwide by early 2026, making available the only FDA-cleared blood test in the U.S. to aid in the initial assessment for ...
LabCorp, one of the largest clinical laboratory companies in the world, is now giving consumers the option to order their own blood tests online as it positions itself for a major expansion of ...
Praia Health’s latest announcements aim to boost patient engagement across health systems by streamlining data and operations ...
The deal includes outreach laboratory services in 13 states. CHS will continue to operate its inpatient and emergency department labs along with other hospital-based testing services. Like its chief ...
Zacks Investment Research on MSN
Labcorp Gears Up to Report Q3 Earnings: What's in Store for the Stock?
Labcorp Holdings Inc. LH, or Labcorp, is slated to report its third-quarter 2025 results on Oct. 28, before the market opens.
Editor’s note: In the second part of WRAL TechWire’s exclusive interview, LabCorp CEO and Chairman David King talks about his rise to the top of the life science giant’s executive suite, striving to ...
Labcorp Holdings Inc. closed 4.84% short of its 52-week high of $293.72, which the company reached on October 21st.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results